John Martin in 2012 (Paul Sakuma/AP Images)
Biotech pioneer and startup investor John Martin, who built Gilead into a powerhouse player, has died
John C. Martin, who led Gilead to greatness in developing a hugely profitable HIV drug franchise, has died.
His death at the age of 69 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
